Lonazolac
From Wikipedia, the free encyclopedia
 |
|
|
Lonazolac
|
|
| Systematic (IUPAC) name | |
| 2-[3-(4-chlorophenyl)-1-phenylpyrazol-4-yl]acetic acid | |
| Identifiers | |
| CAS number | ? |
| ATC code | M01 |
| PubChem | |
| Chemical data | |
| Formula | C17H13ClN2O2 |
| Mol. mass | 312.75032 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Lonazolac is a non-steroidal anti-inflammatory drug.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||||||||||||||||||||||||||
